Skip to main content

Table 2 Univariable and multivariable conditional logistic regression analysis regarding risk of infection with ESBL-producing pathogen (vs. non-ESBL)

From: Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018

  Univariate
OR [95%-CI] (p value)
Multivariable
aOR [95%-CI] (p value)
Male versus female 2.4 [1.0–5.4] (0.04) 2.3 [0.9–5.0] (0.08)
Age (years) at time of infection 1.0 [0.9–1.0] (0.58) 0.9 [0.9–1.0] (0.99)
BMI at transplantation 1.0 [0.9–1.1] (0.92)  
Caucasian versus others 0.4 [0.1–2.1] (0.27)  
Comorbidities (yes/no)
 Cardiopulmonary disease 1.1 [0.6–2.3] (0.72)  
 Metabolic/endocrine disease 0.5 [0.2–1.1] (0.10) 0.4 [0.2–1.1] (0.09)
 Cancer 1.4 [0.4–4.4] (0.57)  
 Other 1.1 [0.5–2.7] (0.82)  
Year of infection
 2012  
 2013 1.2 [0.3–4.7] (0.83)  
 2014 1.6 [0.3–7.1] (0.57)  
 2015 2.5 [0.6–11.1] (0.23)  
 2016 0.9 [0.2–5.3] (0.94)  
Antibiotics (yes/no) before infectiona 2.4 [1.0–5.9] (0.048) 2.6 [1.0–6.8] (0.046)
  1. ESBL extended-spectrum beta-lactamase, (a)OR (adjusted) odds ratio, CI confidence interval, BMI body mass index
  2. aAny therapeutic or prophylactic antibiotic treatment within 30 days prior to infection